SCHEMBL15711339

SCHEMBL15711339

COc1cc(N)c(Nc2cc(N)ncn2)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 6/20 0.42
▸ ERBB3 P21860 3/20 0.42
▸ SCN9A Q15858 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.39
▸ MKNK2 Q9HBH9 1/20 0.39
▸ CDK1 P06493 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ CCNA2 P20248 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ USP2 O75604 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14614677 0.78 MKNK2 (0.43) SCN9AKDRMEN1KMT2AMKNK1
SCHEMBL14614612 0.75 MKNK2 (0.47) SCN9AKDRMKNK1MKNK2CDK1
SCHEMBL13116795 0.73 MAPK10 (0.53) EGFRERBB3CDK2MAPK10GAA
SCHEMBL1094303 0.72 MEN1 (0.53) EGFRERBB3SCN9AKDRMEN1
SCHEMBL28936119 0.72 MKNK1 (0.66) MKNK1
SCHEMBL30781995 0.70 SCN9A (0.50) EGFRERBB3SCN9AKDRMEN1
SCHEMBL15711333 0.69 MAPK10 (0.62) EGFRSCN9AKDRMEN1KMT2A
SCHEMBL9396539 0.69 KDM4E (0.47) MEN1KMT2AGAAMAPTL3MBTL1
SCHEMBL10187337 0.69 MEN1 (0.81) EGFRERBB3SCN9AMEN1KMT2A
SCHEMBL1095089 0.68 MEN1 (0.52) EGFRERBB3SCN9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336122-B1 1-PYRIMIDINYL- OR 1-PYRIDINYL-2-AMINO BENZIMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES FOR THE TREATMENT OF CANCER VERTEX PHARMA (US) 2014-05-14 — — EP disclosed
Send feedback